Related Experiment Video
Updated: Jul 10, 2025
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
1.7K
Omics sciences and precision medicine in thyroid cancer
K Dhuli1, M C Medori1, K Donato2
1MAGI'S LAB, Rovereto (TN), Italy.
La Clinica Terapeutica
|November 23, 2023
Summary
Omics sciences like genomics and proteomics help identify molecular markers for personalized thyroid cancer treatment. Targeted therapies, guided by these markers, show promise in improving patient outcomes, especially for advanced cases.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Thyroid cancer is a prevalent endocrine malignancy with persistent recurrence and mortality.
- Personalized treatment strategies are crucial due to the disease's heterogeneity.
- Omics sciences offer high-throughput methods to explore thyroid cancer's molecular landscape.
Purpose of the Study:
- To review the application of omics sciences in understanding thyroid cancer.
- To highlight the role of molecular markers in diagnosis, prognosis, and treatment selection.
- To discuss the integration of omics data for precision medicine in thyroid cancer.
Main Methods:
- Systematic review of pertinent scientific literature.
- Focused research strategy for selecting emblematic articles.
- Synthesis of existing sources for a thorough and precise overview.
Main Results:
- Genomics identified key alterations (e.g., BRAF, RAS mutations).
- Transcriptomics revealed genes involved in proliferation, invasion, and metastasis.
- Proteomics and metabolomics uncovered biomarkers and altered pathways for early detection and therapeutic targets.
Conclusions:
- Omics sciences provide molecular insights for personalized thyroid cancer therapy.
- Targeted therapies based on molecular markers improve patient prognosis.
- Precision medicine integrating omics data offers advanced treatment options, exemplified by BRAF-mutated thyroid cancer response to targeted drugs.
